These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37525352)

  • 1. Association Between Weight Reduction and Employees' Healthcare Cost.
    Peasah SK; Drnach A; Rosenberg E; Good CB
    J Occup Environ Med; 2023 Dec; 65(12):998-1002. PubMed ID: 37525352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic value of nonsurgical weight loss in adults with obesity.
    Ding Y; Fan X; Blanchette CM; Smolarz BG; Weng W; Ramasamy A
    J Manag Care Spec Pharm; 2021 Jan; 27(1):37-50. PubMed ID: 33164723
    [No Abstract]   [Full Text] [Related]  

  • 3. Productivity loss outcomes and costs among patients with cholangiocarcinoma in the United States: an economic evaluation.
    Parasuraman S; Thiel E; Park J; Teschemaker A
    J Med Econ; 2023; 26(1):454-462. PubMed ID: 36883994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.
    Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Schein J; Kaatz S
    J Manag Care Pharm; 2012 Jun; 18(5):363-74. PubMed ID: 22663169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between employee obesity and employer costs: evidence from a panel of U.S. employers.
    Van Nuys K; Globe D; Ng-Mak D; Cheung H; Sullivan J; Goldman D
    Am J Health Promot; 2014; 28(5):277-85. PubMed ID: 24779722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden of epilepsy among the privately insured in the US.
    Ivanova JI; Birnbaum HG; Kidolezi Y; Qiu Y; Mallett D; Caleo S
    Pharmacoeconomics; 2010; 28(8):675-85. PubMed ID: 20623993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clustering of risk factors for non-communicable disease and healthcare expenditure in employees with private health insurance presenting for health risk appraisal: a cross-sectional study.
    Kolbe-Alexander TL; Conradie J; Lambert EV
    BMC Public Health; 2013 Dec; 13():1213. PubMed ID: 24359466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.
    Rubin DT; Mittal M; Davis M; Johnson S; Chao J; Skup M
    J Manag Care Spec Pharm; 2017 Aug; 23(8):859-867. PubMed ID: 28737994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index and insulin use as identifiers of high-cost patients with type 2 diabetes: A retrospective analysis of electronic health records linked to insurance claims data.
    Johnston SS; Ammann EM; Kashyap SR; Stokes A; Hsiao CC; Daskiran M; Scamuffa R
    Diabetes Obes Metab; 2019 Jun; 21(6):1419-1428. PubMed ID: 30768824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bundled Payment Models for Actinic Keratosis Management.
    Kirby JS; Delikat A; Leslie D; Miller JJ
    JAMA Dermatol; 2016 Jul; 152(7):789-97. PubMed ID: 27028662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complication-specific direct medical costs by body mass index for 13 obesity-related complications: a retrospective database study.
    Divino V; Ramasamy A; Anupindi VR; Eriksen KT; Olsen AH; DeKoven M; Meincke HH
    J Manag Care Spec Pharm; 2021 Feb; 27(2):210-222. PubMed ID: 33307936
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of medication therapy management services for patients with cardiovascular disease in a self-insured employer health plan.
    Wittayanukorn S; Westrick SC; Hansen RA; Billor N; Braxton-Lloyd K; Fox BI; Garza KB
    J Manag Care Pharm; 2013 Jun; 19(5):385-95. PubMed ID: 23697476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of body mass index with health care expenditures in the United States by age and sex.
    Ward ZJ; Bleich SN; Long MW; Gortmaker SL
    PLoS One; 2021; 16(3):e0247307. PubMed ID: 33760880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mean direct medical care costs associated with cervical cancer for commercially insured patients in Texas.
    Lairson DR; Fu S; Chan W; Xu L; Shelal Z; Ramondetta L
    Gynecol Oncol; 2017 Apr; 145(1):108-113. PubMed ID: 28196673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.
    Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J
    J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs.
    Birnbaum HG; Ivanova JI; Samuels S; Davis M; Cremieux PY; Phillips AL; Meletiche D
    Curr Med Res Opin; 2009 Apr; 25(4):869-77. PubMed ID: 19232041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cohort analysis assessing medical and nonmedical cost associated with obesity in the workplace.
    Kleinman N; Abouzaid S; Andersen L; Wang Z; Powers A
    J Occup Environ Med; 2014 Feb; 56(2):161-70. PubMed ID: 24451611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare Costs for Insured Older U.S. Adults with Hearing Loss.
    Simpson AN; Simpson KN; Dubno JR
    J Am Geriatr Soc; 2018 Aug; 66(8):1546-1552. PubMed ID: 29797584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status.
    Cawley J; Meyerhoefer C; Biener A; Hammer M; Wintfeld N
    Pharmacoeconomics; 2015 Jul; 33(7):707-22. PubMed ID: 25381647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.